A Rifai

1.1k total citations
33 papers, 889 citations indexed

About

A Rifai is a scholar working on Nephrology, Rheumatology and Immunology. According to data from OpenAlex, A Rifai has authored 33 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Nephrology, 9 papers in Rheumatology and 9 papers in Immunology. Recurrent topics in A Rifai's work include Renal Diseases and Glomerulopathies (12 papers), Systemic Lupus Erythematosus Research (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). A Rifai is often cited by papers focused on Renal Diseases and Glomerulopathies (12 papers), Systemic Lupus Erythematosus Research (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). A Rifai collaborates with scholars based in United States, Italy and Jordan. A Rifai's co-authors include Parker A. Small, Mart Mannik, E. M. Ayoub, Perry O. Teague, Daniel B. Magilavy, Paul H. Plötz, D S Finbloom, Rujun Gong, Lance D. Dworkin and Katrina G. Millard and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

A Rifai

32 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Rifai United States 18 369 325 255 208 126 33 889
N. Gunnar Westberg United States 14 389 1.1× 226 0.7× 162 0.6× 103 0.5× 245 1.9× 21 944
G Steiger Switzerland 17 127 0.3× 476 1.5× 142 0.6× 87 0.4× 154 1.2× 27 804
Daniel Brandt United States 8 240 0.7× 499 1.5× 139 0.5× 58 0.3× 404 3.2× 12 872
Mary H. Foster United States 16 264 0.7× 710 2.2× 227 0.9× 426 2.0× 545 4.3× 53 1.2k
Perry O. Teague United States 14 190 0.5× 251 0.8× 95 0.4× 132 0.6× 111 0.9× 20 613
Dawn J. Caster United States 13 309 0.8× 241 0.7× 102 0.4× 109 0.5× 432 3.4× 33 694
Stephen R. Holdsworth Australia 9 325 0.9× 449 1.4× 100 0.4× 39 0.2× 147 1.2× 9 806
Masayoshi Miura Japan 17 109 0.3× 473 1.5× 189 0.7× 67 0.3× 37 0.3× 74 1.1k
B. Fekete Hungary 14 61 0.2× 248 0.8× 157 0.6× 65 0.3× 267 2.1× 58 752
Shizuyo Tsujimura Japan 16 64 0.2× 286 0.9× 101 0.4× 224 1.1× 539 4.3× 33 969

Countries citing papers authored by A Rifai

Since Specialization
Citations

This map shows the geographic impact of A Rifai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Rifai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Rifai more than expected).

Fields of papers citing papers by A Rifai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Rifai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Rifai. The network helps show where A Rifai may publish in the future.

Co-authorship network of co-authors of A Rifai

This figure shows the co-authorship network connecting the top 25 collaborators of A Rifai. A scholar is included among the top collaborators of A Rifai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Rifai. A Rifai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rifai, A, Dana A. Alqudah, Hamdi Nsairat, et al.. (2025). Quality by digital design for accelerated sustainable nanomedicine development. European Journal of Pharmaceutical Sciences. 213. 107239–107239. 3 indexed citations
3.
Colvin, Gerald A., et al.. (2010). Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1. Nephrology Dialysis Transplantation. 25(5). 1708–1713. 14 indexed citations
4.
5.
Gong, Rujun, Yan Ge, Emily C. Liang, et al.. (2008). Glycogen Synthase Kinase 3β: A Novel Marker and Modulator of Inflammatory Injury in Chronic Renal Allograft Disease. American Journal of Transplantation. 8(9). 1852–1863. 37 indexed citations
6.
Chao, Tai‐Kuang, A Rifai, Shuk‐Man Ka, et al.. (2006). The endogenous immune response modulates the course of IgA-immune complex mediated nephropathy. Kidney International. 70(2). 283–297. 25 indexed citations
7.
Gong, Rujun, A Rifai, & Lance D. Dworkin. (2006). Hepatocyte growth factor suppresses acute renal inflammation by inhibition of endothelial E-selectin. Kidney International. 69(7). 1166–1174. 46 indexed citations
8.
Roccatello, Dario, Giulia Morsica, Giuseppe Picciotto, et al.. (1997). Impaired hepatosplenic elimination of circulating cryoglobulins in patients with essential mixed cryoglobulinaemia and hepatitis C virus (HCV) infection. Clinical & Experimental Immunology. 110(1). 9–14. 29 indexed citations
9.
Rifai, A, et al.. (1996). Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice.. PubMed. 149(2). 717–25. 55 indexed citations
10.
Cheng, Jack C. Y., A. Raymond Frackelton, Elaine L. Bearer, et al.. (1995). Changes in tyrosine-phosphorylated p190 and its association with p120 type I and p100 type II rasGAPs during myelomonocytic differentiation of human leukemic cells.. PubMed. 6(2). 139–48. 12 indexed citations
11.
Emlen, Woodruff, A Rifai, Daniel B. Magilavy, & Mart Mannik. (1988). Hepatic binding of DNA is mediated by a receptor on nonparenchymal cells.. PubMed. 133(1). 54–60. 44 indexed citations
12.
Rifai, A, et al.. (1988). Glomerular immune deposits in experimental IgA nephropathy. A continuum of circulating and in situ formed immune complexes.. PubMed. 130(1). 216–22. 14 indexed citations
13.
Imai, Hirokazu, et al.. (1987). Influence of the antigen on experimental IgA nephropathy.. PubMed. 7(4). 283–5. 10 indexed citations
14.
Rifai, A, et al.. (1987). IgA molecular form--pathophysiology correlates: immune complex formation and glomerular deposition.. PubMed. 216B. 1515–22. 3 indexed citations
15.
Al-Rodhan, Nayef R. F., Ossama Al‐Mefty, A Rifai, & J. L. Fox. (1986). Persistence of primitive cerebral vasculature in a newborn. Clinical Neurology and Neurosurgery. 88(4). 283–287. 8 indexed citations
16.
Rifai, A, et al.. (1984). Experimental IgA nephropathy. Factors governing the persistence of IgA-antigen complexes in the circulation of mice.. PubMed. 40. 37–44. 12 indexed citations
17.
Rifai, A & Mart Mannik. (1984). Clearance of circulating IgA immune complexes is mediated by a specific receptor on Kupffer cells in mice.. The Journal of Experimental Medicine. 160(1). 125–137. 61 indexed citations
18.
Rifai, A, et al.. (1983). Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA.. The Journal of Immunology. 130(4). 1826–1832. 52 indexed citations
19.
Magilavy, Daniel B., A Rifai, & Paul H. Plötz. (1981). An abnormality of immune complex kinetics in murine lupus.. The Journal of Immunology. 126(2). 770–774. 31 indexed citations
20.
Rifai, A, Parker A. Small, Perry O. Teague, & E. M. Ayoub. (1979). Experimental IgA nephropathy.. The Journal of Experimental Medicine. 150(5). 1161–1173. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026